avapro and angiotensin i

avapro has been researched along with angiotensin i in 24 studies

Research

Studies (24)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	6 (25.00)	18.2507
2000's	13 (54.17)	29.6817
2010's	5 (20.83)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Briand, R; Martineau, D; Yamaguchi, N	1
Cazaubon, C; Chatelain, P; Delisée, C; Schaeffer, P	1
García-Sáinz, JA; González-Espinosa, C; Martínez-Alfaro, M; Romero-Avila, MT	1
Carraway, JW; Holycross, BJ; McCune, SA; Park, S; Radin, MJ	1
Petkun, W	1
Danser, AH; de Vries, R; MaassenVanDenBrink, A; Saxena, PR; Schalekamp, MA	1
Burnier, M	1
Connell, JM; Hillier, C; McDonald, JE; McMurray, JJ; Padmanabhan, N; Petrie, MC	1
Beevers, DG; Lip, GY	1
Danser, AH; de Vries, R; Saxena, PR; Schalekamp, MA; Schuijt, MP	1
Fisher, ND; Hollenberg, NK; Laffel, LM; Lansang, MC; Osei, SY; Price, DA	1
Preobrazhenskiĭ, DV; Sidorenko, BA; Stetsenko, TM; Tarykina, EV; Tsurko, VV	1
Dominiak, P; Häuser, W	1
Bei, R; Bucci, M; Cipollone, F; Cuccurullo, C; Cuccurullo, F; de Cesare, D; De Luca, M; Fazia, M; Iezzi, A; Mezzetti, A; Muraro, R; Pini, B; Spigonardo, F; Ucchino, S; Zucchelli, M	1
Haas, T; Widimský, J; Zizka, J	1
Bramlage, P; Brosnihan, KB; Ferrario, CM; Kirch, W; Koch, R; Maywald, U; Oertel, R; Schindler, C	1
Jing, L; Kou, JJ; Li, S; Li, WM; Song, J; Zhou, LJ	1
Basu, R; Guo, D; Kassiri, Z; Liu, PP; Oudit, GY; Penninger, JM; Scholey, JW; Wang, X; Zhong, J	1
Ager, EI; Chan, J; Chong, WW; Christophi, C; Neo, JH; Wen, SW	1
Basu, R; Bodiga, S; Das, SK; Fan, D; Kassiri, Z; Oudit, GY; Patel, VB; Wang, W; Wang, Z; Zhong, J	1
Erfinanda, L; Gembardt, F; Kaestle, SM; Klein, N; Kuebler, WM; Lei, X; Mertens, M; Nickles, H; Supé, S; Szaszi, K; Walther, T; Wang, L; Yin, J	1
Gao, PJ; Jin, HY; Lu, L; Oudit, GY; Penninger, JM; Shang, QH; Song, B; Xu, YL; Zhang, ZZ; Zhong, JC; Zhou, T; Zhu, DL	1
Al-Jarallah, A; Babiker, F; Joseph, S	1

Reviews

3 review(s) available for avapro and angiotensin i

Article	Year
Angiotensin II type 1 receptor blockers. Circulation, 2001, Feb-13, Volume: 103, Issue:6 Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Binding, Competitive; Biphenyl Compounds; Blood Pressure; Drug Design; Humans; Irbesartan; Losartan; Peptidyl-Dipeptidase A; Protein Binding; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin-Angiotensin System; Saralasin; Tetrazoles; Valine; Valsartan	2001
The protective effect of blocking angiotensin in both type I and type II diabetics with nephropathy. Journal of human hypertension, 2001, Volume: 15, Issue:12 Topics: Aged; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Irbesartan; Losartan; Male; Middle Aged; Primary Prevention; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Sensitivity and Specificity; Tetrazoles; Treatment Outcome	2001
[Angiotensin I receptor antagonist losartan. Part II. Effects in arterial hypertension and diabetic nephropathy]. Kardiologiia, 2003, Volume: 43, Issue:2 Topics: Angiotensin I; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diastole; Diuretics; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Irbesartan; Losartan; Meta-Analysis as Topic; Placebos; Prognosis; Randomized Controlled Trials as Topic; Sodium Chloride Symporter Inhibitors; Systole; Tetrazoles; Time Factors; Treatment Outcome; Valine; Valsartan	2003

Trials

4 trial(s) available for avapro and angiotensin i

Article	Year
Vasoconstrictor effect of the angiotensin-converting enzyme-resistant, chymase-specific substrate [Pro(11)(D)-Ala(12)] angiotensin I in human dorsal hand veins: in vivo demonstration of non-ace production of angiotensin II in humans. Circulation, 2001, Oct-09, Volume: 104, Issue:15 Topics: Administration, Oral; Angina Pectoris; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Captopril; Chronic Disease; Chymases; Dose-Response Relationship, Drug; Double-Blind Method; Hand; Humans; Infusions, Intravenous; Irbesartan; Middle Aged; Peptidyl-Dipeptidase A; Reproducibility of Results; Serine Endopeptidases; Substrate Specificity; Tetrazoles; Vasoconstriction; Veins	2001
Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity. Circulation, 2004, Mar-30, Volume: 109, Issue:12 Topics: Aged; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Biphenyl Compounds; Carotid Artery, Internal; Carotid Stenosis; Chlorthalidone; Collagen; Combined Modality Therapy; Cyclooxygenase 1; Cyclooxygenase 2; Depression, Chemical; Dinoprostone; Endarterectomy, Carotid; Enzyme Induction; Extracellular Matrix; Female; Gene Expression Regulation; Humans; Inflammation; Intramolecular Oxidoreductases; Irbesartan; Isoenzymes; Macrophages; Male; Matrix Metalloproteinase Inhibitors; Membrane Proteins; Prostaglandin-E Synthases; Prostaglandin-Endoperoxide Synthases; Protease Inhibitors; Rupture, Spontaneous; Tetrazoles	2004
[Irbesartan in the treatment of arterial hypertension]. Vnitrni lekarstvi, 2000, Volume: 46, Issue:6 Topics: Angiotensin I; Antihypertensive Agents; Biphenyl Compounds; Female; Humans; Hypertension; Irbesartan; Male; Middle Aged; Tetrazoles	2000
Comparison of inhibitory effects of irbesartan and atorvastatin treatment on the renin angiotensin system (RAS) in veins: a randomized double-blind crossover trial in healthy subjects. Journal of clinical pharmacology, 2007, Volume: 47, Issue:1 Topics: Adult; Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Atorvastatin; Biphenyl Compounds; Compliance; Cross-Over Studies; Double-Blind Method; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Irbesartan; Male; Peptide Fragments; Pyrroles; Renin-Angiotensin System; Tetrazoles; Vasoconstriction; Veins	2007

Other Studies

17 other study(ies) available for avapro and angiotensin i

Article	Year
Inhibition by BMS 186295, a selective nonpeptide AT1 antagonist, of adrenal catecholamine release induced by angiotensin II in the dog in vivo. Canadian journal of physiology and pharmacology, 1995, Volume: 73, Issue:4 Topics: Adrenal Glands; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Catecholamines; Chromatography, High Pressure Liquid; Dogs; Dose-Response Relationship, Drug; Electrochemistry; Heart Rate; Irbesartan; Male; Tetrazoles	1995
Characterization of cardiac angiotensin AT1 receptors by [3H]SR 47436. European journal of pharmacology, 1993, Oct-15, Volume: 247, Issue:2 Topics: Angiotensin I; Angiotensin Receptor Antagonists; Animals; Animals, Newborn; Biphenyl Compounds; Calcium; Cells, Cultured; Heart; Homeostasis; Imidazoles; Irbesartan; Kinetics; Losartan; Myocardium; Pyridines; Rats; Rats, Wistar; Receptors, Angiotensin; Tetrazoles	1993
Characterization of the AT1 angiotensin II receptor expressed in guinea pig liver. The Journal of endocrinology, 1997, Volume: 154, Issue:1 Topics: Angiotensin I; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Binding, Competitive; Biphenyl Compounds; Enzyme Activation; Guinea Pigs; Imidazoles; Irbesartan; Liver; Losartan; Male; Polymerase Chain Reaction; Pyridines; Receptors, Angiotensin; RNA, Messenger; Tetrazoles	1997
[Irbesartan--a new AT1-receptor antagonist (AT1-blocker). Angiotensin-II-receptor antagonists: perspectives of a new therapeutic principle, Wiesbaden, 6 April 1997]. Deutsche medizinische Wochenschrift (1946), 1997, Volume: 122, Issue:37 Suppl Topics: Angiotensin I; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Humans; Hypertension; Irbesartan; Tetrazoles	1997
Comparison of irbesartan with captopril effects on cardiac hypertrophy and gene expression in heart failure-prone male SHHF/Mcc-fa(cp) rats. Journal of cardiovascular pharmacology, 1999, Volume: 33, Issue:3 Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Biphenyl Compounds; Blood Pressure; Body Weight; Captopril; Cardiomegaly; Dose-Response Relationship, Drug; Echocardiography; Gene Expression; Heart Failure; Irbesartan; Isoenzymes; Male; Myosin Heavy Chains; Organ Size; Rats; Rats, Inbred Strains; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin; RNA, Messenger; Systole; Tetrazoles	1999
AT1-receptor blockers. European heart journal, 2000, Volume: 21, Issue:4 Topics: Angiotensin I; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Heart Failure; Humans; Hypertension; Irbesartan; Losartan; Meta-Analysis as Topic; Tetrazoles; Valine; Valsartan	2000
Vasoconstriction by in situ formed angiotensin II: role of ACE and chymase. Cardiovascular research, 1999, Volume: 44, Issue:2 Topics: Adolescent; Adult; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Captopril; Child; Child, Preschool; Chymases; Coronary Vessels; Culture Techniques; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Humans; Imidazoles; Irbesartan; Male; Middle Aged; Oligopeptides; Peptidyl-Dipeptidase A; Pyridines; Serine Endopeptidases; Swine; Tetrazoles; Vasoconstriction	1999
Vasoconstriction is determined by interstitial rather than circulating angiotensin II. British journal of pharmacology, 2002, Volume: 135, Issue:1 Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Carotid Arteries; Dose-Response Relationship, Drug; Femoral Artery; Imidazoles; In Vitro Techniques; Irbesartan; Isoquinolines; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Swine; Tetrahydroisoquinolines; Tetrazoles; Vasoconstriction; Vasoconstrictor Agents	2002
Type 2 diabetes, obesity, and the renal response to blocking the renin system with irbesartan. Diabetic medicine : a journal of the British Diabetic Association, 2002, Volume: 19, Issue:10 Topics: Adult; Angiotensin I; Angiotensin Receptor Antagonists; Biphenyl Compounds; Blood Pressure; Body Mass Index; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Humans; Irbesartan; Linear Models; Male; Middle Aged; Obesity; Renal Circulation; Renin-Angiotensin System; Risk Factors; Tetrazoles; Vasodilator Agents	2002
[Dosage equivalents of AT1-receptor antagonists available in Germany]. Deutsche medizinische Wochenschrift (1946), 2003, Oct-31, Volume: 128, Issue:44 Topics: Acrylates; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Clinical Trials as Topic; Germany; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Olmesartan Medoxomil; Placebos; Telmisartan; Tetrazoles; Therapeutic Equivalency; Thiophenes; Time Factors; Valine; Valsartan	2003
Expression of renin-angiotensin system and peroxisome proliferator-activated receptors in alcoholic cardiomyopathy. Alcoholism, clinical and experimental research, 2008, Volume: 32, Issue:11 Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Biphenyl Compounds; Cardiomyopathy, Alcoholic; Disease Models, Animal; Flavonoids; Irbesartan; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocardium; Peptidyl-Dipeptidase A; PPAR alpha; PPAR gamma; Rats; Rats, Wistar; Renin; Renin-Angiotensin System; Tetrazoles; Ventricular Remodeling	2008
Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction. Circulation. Heart failure, 2009, Volume: 2, Issue:5 Topics: Adaptation, Physiological; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Biphenyl Compounds; Disease Models, Animal; Enzyme Activation; Inflammation Mediators; Irbesartan; Male; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitogen-Activated Protein Kinases; Myocardial Infarction; Myocardium; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; Phosphorylation; Receptor, Angiotensin, Type 1; RNA, Messenger; Superoxides; Tetrazoles; Time Factors; Ultrasonography; Ventricular Remodeling	2009
Altered efficacy of AT1R-targeted treatment after spontaneous cancer cell-AT1R upregulation. BMC cancer, 2011, Jun-26, Volume: 11 Topics: Adenocarcinoma; Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers, Tumor; Biphenyl Compounds; Captopril; Colorectal Neoplasms; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Gene Expression Regulation, Neoplastic; Irbesartan; Liver Neoplasms, Experimental; Mice; Mice, Inbred CBA; Molecular Targeted Therapy; Neoplasm Proteins; Neovascularization, Pathologic; Oligopeptides; Peptide Fragments; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Tetrazoles; Tumor Burden; Up-Regulation; Vascular Endothelial Growth Factor A	2011
Cardioprotective effects mediated by angiotensin II type 1 receptor blockade and enhancing angiotensin 1-7 in experimental heart failure in angiotensin-converting enzyme 2-null mice. Hypertension (Dallas, Tex. : 1979), 2012, Volume: 59, Issue:6 Topics: Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Blotting, Western; Cardiotonic Agents; Cells, Cultured; Drug Synergism; Enzyme Activation; Female; Heart; Heart Failure; Irbesartan; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; NADPH Oxidases; Peptide Fragments; Peptidyl-Dipeptidase A; Reverse Transcriptase Polymerase Chain Reaction; Superoxides; Systole; Tetrazoles	2012
Angiotensin-(1-7) protects from experimental acute lung injury. Critical care medicine, 2013, Volume: 41, Issue:11 Topics: Acute Lung Injury; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Electric Impedance; Endothelial Cells; Hemodynamics; Imidazoles; Irbesartan; Male; Mice; Mice, Inbred C57BL; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Respiratory Mechanics; Tetrazoles	2013
Cardiac protective effects of irbesartan via the PPAR-gamma signaling pathway in angiotensin-converting enzyme 2-deficient mice. Journal of translational medicine, 2013, Sep-25, Volume: 11 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Biphenyl Compounds; Cardiomegaly; Cardiotonic Agents; Collagen; Connective Tissue Growth Factor; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Gene Expression Regulation; Irbesartan; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Peptide Fragments; Peptidyl-Dipeptidase A; Phosphorylation; PPAR alpha; PPAR delta; PPAR gamma; Receptor, Angiotensin, Type 1; RNA, Messenger; Signal Transduction; Tetrazoles; Transforming Growth Factor beta	2013
The Interplay between the Renin Angiotensin System and Pacing Postconditioning Induced Cardiac Protection. PloS one, 2016, Volume: 11, Issue:11 Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Captopril; Cardiac Pacing, Artificial; Heart; Hemodynamics; Irbesartan; Male; Myocardial Reperfusion Injury; Myocardium; Peptide Fragments; Rats; Rats, Wistar; Receptors, Angiotensin; Renin-Angiotensin System; Tetrazoles	2016

chemdatabank.com